Dedifferentiated chondrosarcoma revisited.

Journal and index pages often block iframe embedding. This reader keeps the evidence details in Orthonotes and leaves the source page one click away.

Abstract

[Indexed for MEDLINE] 9. Eur J Surg Oncol. 2022 Nov;48(11):2299-2307. doi: 10.1016/j.ejso.2022.09.011. Epub 2022 Sep 17. Management of pelvic sarcoma. Lee JS(1), Kelly CM(2), Bartlett EK(3). Author information: (1)Department of Surgery, Duke University, Durham, NC, USA. (2)Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. (3)Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA. Electronic address: bartlete@mskcc.org. Pelvic sarcomas are a rare and heterogenous group of tumors divided into two groups: soft tissue sarcomas and bone sarcomas. Soft tissue sarcomas of the pelvis include most commonly liposarcoma, leiomyosarcoma, gastrointestinal stromal tumors, malignant peripheral nerve sheath tumors, and solitary fibrous tumors. Bone sarcomas of the pelvis most commonly include osteosarcoma and chondrosarcoma. Multidisciplinary treatment at a center experienced in the treatment of sarcoma is essential. Management is dictated by histologic type and grade. Surgical resection with wide margins is the cornerstone of treatment for pelvic sarcomas, although this is often challenging due to anatomic constraints of the pelvis. Multimodal treatment is critical due to the high risk of local recurrence in the pelvis. Copyright © 2022 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved. DOI: 10.1016/j.ejso.2022.09.011